Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
A completed clinical trial observing the use of Micardis (telmisartan) in patients with essential hypertension in hospital settings.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension
A completed clinical trial update assessing Motens (lacidipine) for essential hypertension, reporting observed efficacy and tolerability/saf…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension [Phase 2]
This Phase 2 trial evaluating the 24-hour antihypertensive efficacy of fimasartan 30 mg with valsartan 80 mg as reference has completed in p…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia [Phase 3]
Phase 3 study evaluating the efficacy of valsartan/simvastatin combinations in patients with essential hypertension and hypercholesterolemia…
-
CLINICAL_TRIALS research · 2014-08-15Clinical Trial Update: Treatment of HYpertension: Morning Versus Evening [Phase 4]
This Phase 4 clinical trial from Erasmus Medical Center investigates whether morning versus evening dosing of antihypertensive therapy affec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension [Phase 3]
Phase 3 trial evaluating telmisartan using ambulatory blood pressure monitoring in Chinese patients with essential hypertension has complete…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Micardis®. Observational Study in Patients With Essential Hypertension
This update reports the completion of an observational study of telmisartan (Micardis) in adults with essential hypertension; no new regulat…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension [Phase 3]
A Phase 3 trial of Lacidipine in patients with mild to moderate essential hypertension has completed. This document provides a status update…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Micardis® in Patients With Essential Hypertension
An update on a completed clinical trial of Micardis (telmisartan) for essential hypertension. The trial was sponsored by Boehringer Ingelhei…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension [Phase 3]
Phase 3 trial update comparing telmisartan with the combination of losartan and hydrochlorothiazide in adults with mild-to-moderate essentia…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: BIBR 277 Capsule in Patients With Essential Hypertension [Phase 3]
Phase 3 trial update: Boehringer Ingelheim's BIBR 277 Capsule in essential hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
This completed clinical trial evaluated the safety, tolerability, and efficacy of Micardis (telmisartan) in adults with essential hypertensi…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension [Phase 4]
Phase 4 trial comparing a low-dose nifedipine-valsartan combination to up-titrated valsartan monotherapy in essential hypertension has compl…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension [Phase 3]
A Phase 3 trial comparing the effects of Eprosartan versus Eprosartan Mesylate on blood pressure in adults with essential hypertension; the …
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension [Phase 2]
This document reports a Phase 2 dose-selection trial evaluating the combination of candesartan cilexetil and amlodipine besylate for essenti…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone [Phase 3]
Phase 3 study evaluating the effectiveness and safety of a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients wit…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension [Phase 1]
Phase 1 randomized, double-blind, placebo-controlled exploratory study to assess safety, tolerability, pharmacokinetics, and hemodynamic res…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension [NA]
This clinical trial update reports the termination of a study investigating aldosterone blockade to prevent myocardial remodeling in patient…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension [Phase 2]
This clinical trial update reports a completed Phase 2 study evaluating nebivolol's effects on the NO-system in patients with essential hype…
-
CLINICAL_TRIALS research · 2014-03-04Clinical Trial Update: Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones [NA]
This clinical trial update reports on a study evaluating whether renal denervation affects NO-mediated sodium excretion and plasma vasoactiv…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension. [Phase 2, Phase 3]
A clinical trial evaluating the efficacy and safety of combining TAK-536CCB with hydrochlorothiazide in patients with Grade I or II essentia…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension [Phase 3]
A Phase 3 trial comparing carvedilol sustained-release to carvedilol immediate-release in adults with essential hypertension to evaluate com…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351) [Phase 3]
A Phase 3 long-term safety study of MK-0954A in patients with essential hypertension completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine [Phase 3]
This Phase 3 trial update reports on evaluating aliskiren in combination with amlodipine for hypertensive patients not responding to ARB plu…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension [Phase 3]
Phase 3 study evaluating the trough and peak effect of once-daily telmisartan 80 mg with hydrochlorothiazide 12.5 mg (Micardis Plus) using a…